Telminuvo Tablet 40/5 mg (Telmisartan, Esamlodipine Besilate Hydrate)

Adult dose

The recommended dosage for this medication is 1 tablet once daily, to be taken with water regardless of meals. It is advised to take it at the same time each day (e.g., in the morning) if possible. For renal impairment patients, no dosage adjustment is needed for mild to moderate renal impairment, but severe renal impairment patients should start with a lower dosage and gradually increase. For liver impairment patients, the daily dosage of telmisartan should not exceed 40 mg for mild to moderate liver impairment.

Child dose

Use in pediatric patients under 18 years of age is not recommended due to the lack of established safety and efficacy.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication is contraindicated in patients with an allergy to the active ingredients or specific heart diseases, liver dysfunctions, and severe hypotension. Caution is required for patients with liver dysfunction, gastrointestinal diseases, kidney impairment, and the elderly when using this medication. Blood pressure may drop too low, so if symptoms of hypotension occur, the patient should lie down immediately and receive necessary treatment. This medication can increase blood potassium levels, so caution is needed when taken with potassium-rich medications or supplements. Patients with poor kidney function should regularly have blood tests to check kidney status and electrolyte levels. This medication can cause drowsiness or dizziness, so caution is required during driving or operating hazardous machinery. There may be interactions with other medications, particularly with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs, so consultation with a professional is advised when taken concurrently. In case of overdose, symptoms such as hypotension, arrhythmia, and renal failure may occur, requiring immediate medical attention. Safety and efficacy in children have not been adequately established, so use in this population is not recommended. This medication should be stored out of the reach of children and should not be transferred to other containers.

Serious side effects

Severe allergic reactions (including urticaria, angioedema, anaphylaxis), severe skin reactions (including urticaria, angioedema, toxic epidermal necrolysis, Stevens-Johnson syndrome), respiratory problems (including difficulty breathing, asthma attacks), liver abnormalities (jaundice), severe neurological symptoms (severe headaches, fainting, etc.), severe swelling or urination problems (renal dysfunction, acute renal failure, significantly decreased urine output, swelling accompanied by increased blood pressure)

Mild side effects

• Headache
• peripheral edema
• swelling
• palpitations
• dizziness
• increased SGOT
• nausea
• increased platelets
• upper respiratory infections
• urinary tract infections

This medication should be stored in a tightly closed container to avoid exposure to air and humidity. It should be kept at room temperature between 1 and 30 degrees Celsius, avoiding very hot or very cold places.

Appearance

Pale yellow - egg-shaped tablet with two layers of blue color

Package unit

30 tablets/bottle